BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25400723)

  • 1. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
    Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
    Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
    Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
    Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma.
    Zhou Y; Lan J; Wang W; Shi Q; Lan Y; Cheng Z; Guan H
    J Mol Histol; 2013 Oct; 44(5):555-63. PubMed ID: 23504200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
    Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
    J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
    Gao J; Zhao C; Liu Q; Hou X; Li S; Xing X; Yang C; Luo Y
    J Exp Clin Cancer Res; 2018 Dec; 37(1):317. PubMed ID: 30547803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
    Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
    Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
    Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
    Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXB5 induces invasion and migration through direct transcriptional up-regulation of β-catenin in human gastric carcinoma.
    Hong CS; Jeong O; Piao Z; Guo C; Jung MR; Choi C; Park YK
    Biochem J; 2015 Dec; 472(3):393-403. PubMed ID: 26467157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
    Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
    Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Wnt1-inducible signaling pathway protein-1 with the proliferation, migration and invasion in gastric cancer cells.
    Jia S; Qu T; Feng M; Ji K; Li Z; Jiang W; Ji J
    Tumour Biol; 2017 Jun; 39(6):1010428317699755. PubMed ID: 28618940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RSPO2 enhances cell invasion and migration via the WNT/β-catenin pathway in human gastric cancer.
    Zhang H; Han X; Wei B; Fang J; Hou X; Lan T; Wei H
    J Cell Biochem; 2019 Apr; 120(4):5813-5824. PubMed ID: 30362605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMX1A inhibits metastasis of gastric cancer cells through negative regulation of β-catenin.
    Feng L; Xie Y; Zhao Z; Lian W
    Cell Biol Toxicol; 2016 Apr; 32(2):133-9. PubMed ID: 27061089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSulf-1 inhibits cell proliferation and invasion in human gastric cancer.
    Li J; Mo ML; Chen Z; Yang J; Li QS; Wang DJ; Zhang H; Ye YJ; Li HL; Zhang F; Zhou HM
    Cancer Sci; 2011 Oct; 102(10):1815-21. PubMed ID: 21722266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer.
    Qin S; Zhang Z; Li J; Zang L
    Oncol Rep; 2014 May; 31(5):2351-7. PubMed ID: 24676361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
    Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z
    Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin promotes the metastasis of gastric carcinoma through the β-catenin/TCF-4 pathway.
    Zhuang K; Yan Y; Zhang X; Zhang J; Zhang L; Han K
    Oncol Rep; 2016 Sep; 36(3):1369-76. PubMed ID: 27430592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.